
Sms Pharmaceuticals (SMSPHARMA) | Stock Overview & Key Data
Sms Pharmaceuticals Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹398.00 on September 23, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Sms Pharmaceuticals SMSPHARMA | 23.10B Small-cap | -7.69% | 9.34% | 3.92% | 17.65% | 0.50% | -29.15% | 185.52% | 181.63% |
GlaxoSmithKline GLAXO | 458.57B Large-cap | -1.79% | -3.96% | -19.57% | -3.58% | 20.84% | -1.52% | 93.34% | 80.13% |
Pfizer PFIZER | 231.58B Large-cap | 2.92% | 0.31% | -9.61% | 27.62% | -2.95% | -8.29% | 16.04% | 2.57% |
Senores SENORES | 32.95B Small-cap | -4.06% | -1.93% | 18.10% | 22.01% | 20.44% | 20.06% | 20.06% | 20.06% |
TTK Healthcare TTKHLTCARE | 16.28B Small-cap | -2.66% | 0.24% | -9.50% | -1.96% | -17.55% | -28.09% | 21.98% | 161.51% |
Kopran KOPRAN | 8.76B Small-cap | -3.91% | 10.93% | -5.79% | -6.24% | -17.43% | -43.97% | 6.92% | 92.78% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SMSPHARMA's 52-week high and low?
- In the last 52 weeks, Sms Pharmaceuticals reached a high of ₹390.85 (on October 3, 2024) and a low of ₹176.05 (on March 3, 2025).
- What is the market cap and P/E ratio for SMSPHARMA?
- Curious about Sms Pharmaceuticals's size and valuation? Its market capitalization stands at 23.10B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.80, and the forward P/E (looking ahead) is N/A.
- Does SMSPHARMA pay dividends? If so, what's the yield?
- Yes, Sms Pharmaceuticals is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.28%, and the company has paid an average of ₹0.37 per share annually over the past 3 years.
- Who are Sms Pharmaceuticals's main competitors or similar companies to consider before investing?
When looking at Sms Pharmaceuticals, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO458.57B Healthcare Drug Manufacturers - General -1.52% 93.34% Pfizer
PFIZER231.58B Healthcare Drug Manufacturers - General -8.29% 16.04% Senores
SENORES32.95B Healthcare Drug Manufacturers - General 20.06% 20.06% TTK Healthcare
TTKHLTCARE16.28B Healthcare Drug Manufacturers - General -28.09% 21.98% Kopran
KOPRAN8.76B Healthcare Drug Manufacturers - General -43.97% 6.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sms Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Sms Pharmaceuticals's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.81%, the Debt to Equity ratio from the most recent quarter is 48.58, and its Gross Profit Margin stands at 33.33%.
- What is the recent revenue and earnings growth for SMSPHARMA?
- Looking at Sms Pharmaceuticals's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.20%, and quarterly earnings saw a YoY growth of 24.30%.
- How much of SMSPHARMA stock is held by insiders and institutions?
- Wondering who owns Sms Pharmaceuticals stock? Company insiders (like executives and directors) hold about 75.04% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.